Significant increase in the incidence of coronavirus infection and lack of availability of specific medicine or vaccine drive the growth of the global Covid-19 diagnostics market.
The Covid-19 diagnostics market garnered $7.1 million in the first quarter of 2020, and is expected to generate $445.4 million by the fourth quarter of 2020. The report offers an extensive analysis of changing market dynamics, business performance, industry roadmap, and competitive scenario.
Significant increase in the incidence of coronavirus infection and lack of availability of specific medicine or vaccine drive the growth of the global Covid-19 diagnostics market. However, scarcity of diagnostic kits hinders the market growth. On the other hand, the advancements in the diagnostic kits and expansion of leading players in emerging economies create opportunities in the coming years.
Download Sample Report with Detailed COVID-19 Impact Analysis at: https://www.alliedmarketresearch.com/request-for-customization/6945?reqfor=covid
Covid-19 scenario:
- The importance of Covid-19 diagnostic tools has been highlighted due to the unavailability of specific medicine or vaccine, even though the several trials for vaccine development and potential treatments are ongoing.
- The groups of population that should be given a priority for immunization have been pointed out and diagnostic testing activities have been carried out for them.
The report offers a detailed segmentation of the global Covid-19 diagnostics market based on product, technology, end user, and region.
Based on technology, the majority of share was contributed by molecular segment in first quarter of 2020, and is estimated to maintain its lead position during the fourth quarter of 2020.
Based on end user, the majority of share was contributed by the diagnostic labs segment, accounting for more than two-thirds of the total share in the first quarter of 2020, and is expected to maintain the its dominance up to the fourth quarter of 2020.
Based on region, Europe will maintain its dominance throughout the forecast period and contributed the majority share with more than half of the total share in the first quarter of 2020. In addition, the report provides the analysis of the regions including North America, Asia-Pacific, and LAMEA during the forecast period.
Leading market players analyzed in the research include Seegene Inc., Thermo Fisher Scientific, Inc., Cepheid, Genematrix, Robert Bosch GmbH, F. Hoffmann-La Roche AG, MylabLifesolutions Pvt. Ltd., SureScreen Diagnostics Ltd., and Cellex Inc.
Scope of the Report:
| Report Attribute | Details |
| Market size available for years | 2020-2022 |
| Base year considered | 2020 |
| Forecast period | 2019-2022 |
| Forecast units | Value (USD) |
| Segments covered | Product, Technology, and End User |
| Geographies covered | North America, Europe, Asia-Pacific, LAMEA |
Similar Reports With COVID-19 Analysis:
- Sexually Transmitted Diseases (STD) Testing Market by Disease Type (Chlamydia, Syphilis, Gonorrhea, Herpes Simplex Virus, Human Papilloma Virus, Human Immunodeficiency Virus, and Others), and Location of Testing (Laboratory Testing and POC Testing): Global Opportunity Analysis and Industry Forecast, 2018–2025
- Cardiac Biomarkers Market by Type (Myocardial muscle Creatine Kinase (CK-MB), Troponins (T and I), Myoglobin, Brain Natriuretic Peptide (BNPs) or NT-proBNP, Ischemia Modified Albumin (IMA)), Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis) and Location of Testing (Point of care, Laboratory)- Global Opportunity Analysis and Industry Forecast, 2019 – 2026
- Biopsy Devices Market by Product (Needle-Based Biopsy Instruments, Biopsy Forceps, Localization Wires, and Other Products), Application (Breast Biopsy, Gastroenterology Biopsy, Prostate Biopsy, Liver Biopsy, Lung Biopsy, Kidney Biopsy, Gynecological Biopsy, and Others), Imaging Technology (MRI–guided Biopsy, Stereotactic–guided Biopsy, Ultrasound–guided Biopsy, CT scan, and Others), and End User (Diagnostic and Imaging Centers, Hospitals, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026
- Sleep Aids Market by Product (Mattress & Pillows, Sleep Laboratories, Medications, and Sleep Apnea Devices) and Sleep Disorder (Insomnia, Sleep Apnea, Restless Leg Syndrome, Narcolepsy, Sleep Walking, and Other Sleep Disorders) – Global Opportunity Analysis and Industry Forecast, 2019-2026
- Prefilled Syringes Market by Material (Glass-based and Plastic-based), Design (Single-chamber Prefilled Syringes, Dual-chamber Prefilled Syringes, and Customized Prefilled Syringes), Therapeutic (Large Molecules and Small Molecules), and Application [Anaphylaxis, Rheumatoid Arthritis, Diabetes, and Others (Cancer, Multiple Sclerosis, and Others)] – Global Opportunity Analysis and Industry Forecast, 2019-2026
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975